Vimarsana
Biggest News Aggregation in the World

Page 12 - Diffusion Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diffusion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diffusion Pharmaceuticals Today - Breaking & Trending Today

Research Analysts' New Coverage for April 19th (AAWW, ADES, ADMP, ADXS, AGFS, AGLE, AIMC, AJRD, AKAM, APA) - Vimarsana News

Research Analysts' New Coverage for April 19th (AAWW, ADES, ADMP, ADXS, AGFS, AGLE, AIMC, AJRD, AKAM, APA)

Research Analysts’ new coverage for Wednesday, April 19th: StockNews.com began coverage on shares of Atlas Air Worldwide (NASDAQ:AAWW). The firm issued a hold rating on the stock. StockNews.com initiated coverage on shares of Advanced Emissions Solutions (NASDAQ:ADES). StockNews.com issued a hold rating on the stock. StockNews.com initiated coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP). They […]

Source: wkrb13.com
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Short Interest Down 48.4% in March - Vimarsana News

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Short Interest Down 48.4% in March

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 4,900 shares, a drop of 48.4% from the March 15th total of 9,500 shares. Currently, 0.2% of the shares of the company are sold […]

StockNews.com Begins Coverage on Diffusion Pharmaceuticals (NASDAQ:DFFN) - Vimarsana News

StockNews.com Begins Coverage on Diffusion Pharmaceuticals (NASDAQ:DFFN)

StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report released on Tuesday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Price Performance Shares of DFFN opened at $4.29 on Tuesday. The firm has a market cap of $8.74 million, a P/E ratio of -0.56 and […]

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Short Interest Down 48.4% in March - Vimarsana News

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Short Interest Down 48.4% in March

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a large decline in short interest in March. As of March 31st, there was short interest totalling 4,900 shares, a decline of 48.4% from the March 15th total of 9,500 shares. Based on an average trading volume of 8,200 shares, the short-interest ratio is […]

Diffusion Pharmaceuticals (NASDAQ:DFFN) Earns Hold Rating from Analysts at StockNews.com - Vimarsana News

Diffusion Pharmaceuticals (NASDAQ:DFFN) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note released on Monday morning. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Price Performance Diffusion Pharmaceuticals stock opened at $3.82 on Monday. Diffusion Pharmaceuticals has a 12 month low of $3.80 and a 12 month high […]